<div class="white-sheet">
	<div class="content-slide">

		<!-- Secondary scene 1 -->
		<div class="content secondary-scene">

		<div class="title-bar red"></div>

		<div class="wrapper slide-3-3-3">

			<div class="vertical-nav">
                <ul class="two">
                    <li class="active"></li>
                    <li></li>
                </ul>
            </div>

			<div class="popups" style="position:absolute">
				<div data-effect="fade" data-duration="1000" data-target="references-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>
				<div data-effect="fade" data-duration="1000" data-target="information-overlay" data-width="600" data-height="490" class="information-button show-overlay"></div>
			</div>

			<div class="slide-title red two-line">
				Phase II study: eltrombopag can produce a multilineage<br /> response over time in refractory aplastic anaemia
			</div>


			<div class="content-container">

				<table class="red">
					<tr>
						<th>Responders to eltrombopag (n=17)</td>
						<th>Primary response</td>
						<th>Response at last<br /> assessment</td>
					</tr>
					<tr class="odd">
						<td colspan="3" style="font-weight:bold">Haematological response criteria, n (%)</td>
					</tr>
					<tr>
						<td>Unilineage</td>
						<td>13 (76)</td>
						<td>6 (35)</td>
					</tr>
					<tr class="odd">
						<td>Multilineage</td>
						<td>4 (24)</td>
						<td>8 (47)</td>
					</tr>
					<tr>
						<td>
							<ul>
								<li><span>Bilineage</span></li>
							</ul>	
						</td>
						<td>3 (18)</td>
						<td>4 (24)</td>
					</tr>
					<tr class="odd">
						<td>
							<ul>
								<li><span>Trilineage</span></li>
							</ul>
						</td>
						<td>1 (6)</td>
						<td>4 (24)</td>
					</tr>
					<tr>
						<td>Relapsed by last assessment</td>
						<td></td>
						<td>3 (18)</td>
					</tr>
					<tr class="odd">
						<td colspan="3" style="font-weight:bold">Haematological response by cell lineage, n (%)</td>
					</tr>
					<tr>
						<td>Platelets</td>
						<td>11 (65)</td>
						<td>11 (65)</td>
					</tr>
					<tr class="odd">
						<td>Erythrocytes</td>
						<td>3 (18)</td>
						<td>5 (29)</td>
					</tr>
					<tr>
						<td>Neutrophils</td>
						<td>8 (47)</td>
						<td>10 (59)</td>
					</tr>
				</table>

			</div>

		</div>


		<div class="references-overlay overlay">

			<header>References</header>
				
			<ul>
				<li class="navigateHref" data-navtarget="media/documents/module3/GlaxoSmithKline-2014-DoF-ELT112523.pdf"><span>GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014</span></li>
			</ul>

		</div>

		<div class="information-overlay overlay">

			<header>Phase II study: eltrombopag produces a multilineage response over time in refractory aplastic anaemia</header>
				
			<ul>
				<li><span>Of the 17 patients from cohort 1 who achieved the primary endpoint, 14 entered the extension arm</span>
					<ul>
						<li><span>Of these, six had improvement in more than 1 cell lineage after continued eltrombopag treatment</span>
						<ul>
							<li><span>Three patients with a unilineage response improved to a bilineage response</span></li>
							<li><span>One patient with a unilineage response achieved a trilineage response</span></li>
							<li><span>Two patients with a bilineage response improved to a trilineage response</span></li>
						</ul>
							
						</li>
						
					</ul>
				</li>
				<li><span>In 14 patients, the last response assessed was the same as the best response</span></li>
			</ul>

		</div>

		</div>

		<!-- End of secondary scene 1 -->
		<!-- Secondary scene 2 -->
		<div class="content secondary-scene">

		<div class="title-bar blue"></div>

		<div class="wrapper slide-3-3-3a">

			<div class="vertical-nav">
                <ul class="two">
                    <li></li>
                    <li class="active"></li>
                </ul>
            </div>

			<div class="popups" style="position:absolute">
				<div data-effect="fade" data-duration="1000" data-target="references2-overlay" data-width="600" data-height="490" class="references-button show-overlay"></div>
				<div data-effect="fade" data-duration="1000" data-target="information2-overlay" data-width="600" data-height="490" class="information-button show-overlay"></div>
			</div>

			<div class="slide-title blue two-line">
				Phase II study in refractory aplastic anaemia:<br /> normalisation of bone marrow cellularity
			</div>


			<div class="content-container">

				<table class="blue wide">
					<tr>
						<th>Bone marrow cellularity at baseline and after >8 months of treatment with eltrombopag<sup>1</sup></th>
					</tr>
					<tr>
						<td><img src="media/images/slide_3-3-3/picture1.png" alt=""></td>
					</tr>
				</table>
			</div>

		</div>


		<div class="references2-overlay overlay">

			<header>References</header>
				
			<ol>
				<li class="navigateHref" data-navtarget="media/documents/module3/OlnesM-2012-NEJM-v367p11.pdf"><span>Adapted from Olnes M <i>et al. N Engl J Med</i> 2012;367:11</span></li>
				<li class="navigateHref" data-navtarget="media/documents/module3/GlaxoSmithKline-2014-DoF-ELT112523.pdf"><span>GlaxoSmithKline. Data on File. Clinical study report #ELT112523. 2014</span></li>
			</ol>

		</div>


		<div class="information2-overlay overlay">

			<header>Phase II study in refractory aplastic anaemia: normalisation of bone marrow cellularity</header>
				
			<ul>
				<li><span>At baseline, 15 of the 17 patients who responded to eltrombopag had hypocellular bone marrow ranging from ‘variable’ to ‘severe’<sup>2</sup></span></li>
				<li><span>During treatment with eltrombopag, normalisation of bone marrow cellularity occurred in five responders<sup>2</sup></span>
					<ul>
						<li><span>Median duration of treatment (649 days [range 274–812])</span></li>
					</ul>
				</li>
				<li><span>Seven additional responders demonstrated improved bone marrow cellularity from baseline<sup>2</sup></span></li>
				<li><span>No difference from baseline assessment was noted in five patients<sup>2</sup></span></li>
			</ul>

		</div>

		</div>
		<!-- End of secondary scene 2 -->

	</div>
</div>